Home Monitoring in New York

Oova, Inc. manufactures at-home hormone-tracking test kits and digital health platform for fertility and perimenopause management. The company's core product is a urine-based test strip that quantitatively measures luteinizing hormone (LH), E3G (estrogen metabolite), and PdG (progesterone metabolite). Users scan test strips with a smartphone camera; proprietary AI-powered software analyzes hormone levels in real time and delivers personalized insights via a mobile app. Oova claims 99% lab-accuracy correlation to blood testing. The platform includes HIPAA-compliant provider-reporting tools enabling seamless data sharing with healthcare providers; 400+ clinics have integrated Oova. The company offers two guided product lines: Fertility Hormone Kit (for ovulation tracking and conception planning) and Perimenopause Hormone Kit (for tracking hormone fluctuations during midlife transitions). Clinical validation by Mount Sinai physicians; recognized by American Society for Reproductive Medicine (ASRM), American College of Obstetricians and Gynecologists (ACOG), and The Menopause Society. The Oova Membership tier includes 1:1 expert consultations, peer community access, and 30% discounts on test kits. The app functions as a free symptom tracker independently of test strips. Target markets include women trying to conceive, those with PCOS or irregular cycles, perimenopause patients, and those optimizing reproductive health through cycle syncing.

CareTech Human manufactures FDA-registered, sensor-enabled medical devices for urology and remote patient monitoring. The company's flagship product simplifies uroflowmetry procedures through user-friendly technology integrated with automated symptom severity scoring and AI-powered data processing. The system enables objective health assessment with real-time patient compliance tracking, generating clinical-grade data suitable for both hospital and home use. CareTech's solution supports evidence-based clinical decision-making by delivering precise, actionable metrics while facilitating reimbursement through recognized remote monitoring codes. The platform prioritizes health data security and privacy, with clinical trial-ready technology designed for seamless integration into existing hospital workflows and urology practices.

Neko Health AB operates a preventive health screening service offering comprehensive full-body health assessments conducted at dedicated health centres. The company uses advanced multimodal scanning technology to capture measurements across body composition, blood vessels, heart rhythm, immune system markers, metabolism, and peripheral arteries, generating actionable health data within minutes. Clinical results are delivered immediately to patients with unrushed physician consultation included in the service. The company operates a doctor-led model of care emphasizing longitudinal health tracking and early disease detection through annual benchmark comparisons. Operating locations include four health centres in London (Covent Garden, Marylebone, Spitalfields, Victoria), one in Manchester (Lincoln Square), one in Birmingham (Colmore Row), and one in Stockholm (Östermalmstorg), with plans for expansion. Services are priced at £299 per scan. The organization collects aggregated health data for research purposes and maintains a membership model. Neko Health focuses on preventive medicine and wellness monitoring for health-conscious individuals seeking proactive health management rather than reactive clinical intervention.

CooperVision is a global leader in soft contact lens manufacturing and distribution, serving over 130 countries with innovations in vision correction. The company manufactures and markets a comprehensive portfolio of daily disposable, 2-week, and monthly replacement soft contact lenses for spherical, toric (astigmatism), and multifocal (presbyopia) corrections. Key product families include MyDay® daily disposables (including MyDay Energys® for digital eye strain), clariti® 1 day (budget-friendly option), MiSight® 1 day (FDA-approved for pediatric myopia control), Biofinity® monthly lenses (premium comfort), and Avaira Vitality® 2-week lenses. CooperVision utilizes silicone hydrogel and hydrogel material technologies, with features such as UV blockers and lipid-corralling technology for extended wear comfort. The company holds FDA approval for MiSight® 1 day for myopia control in children ages 8–12, and markets lenses with claimed advantages in breathability, comfort, visual clarity, and ease of handling. CooperVision operates as part of CooperCompanies and serves millions of contact lens wearers globally through eye care professionals, optometrists, and ophthalmologists. The company emphasizes innovation in contact lens design, material science, and myopia management solutions for the consumer vision care market.

ZiphyCare is a comprehensive telemedicine and remote care platform designed to expand access to high-quality medical care through technology-enabled home health visits and virtual consultations. The company operates a dual model: proprietary software applications and a patented, FDA-registered portable diagnostic kit (ZiphyKit) that enables clinicians to conduct complete physical examinations remotely. ZiphyKit includes hospital-grade devices for blood pressure measurement, pulse oximetry, ECG, digital stethoscopy, and focused visual examinations (eye, ear, throat, wound). The platform integrates with electronic medical records systems in FHIR format for seamless data management. ZiphyCare serves hospitals, medical groups, health plans, and care-at-home organizations. The software suite comprises ZiphyDoc (provider-facing clinical data and decision support), ZiphyStream (remote care with advanced data collection and conferencing), ZiphyApp (patient coordination and care delivery), MyZiphy (patient portal), ZiphyAdmin (operational management), and ZiphyOutreach (scheduling and mass booking). The platform is designed for mobile workflows, automating care coordination, optimizing transitions of care, reducing no-shows and readmissions, and improving HEDIS metrics and STAR Ratings for health plans. ZiphyCare targets underserved populations, including those with technology barriers, health literacy challenges, and limited access to traditional in-person care. The company provides low-cost APIs and integration tools for health technology companies and care delivery organizations seeking to embed telemedicine capabilities.

CoachCare is a remote patient monitoring (RPM) and virtual health software platform designed for independent physicians, physician groups, and health systems. The company provides a comprehensive digital health suite combining secure video visits, at-home vital sign capture, digital patient forms, and real-time connected device integration. CoachCare's platform automates clinical workflows, patient engagement, and administrative tasks including scheduling, reporting, and HIPAA-compliant messaging. A core strength is integrated revenue cycle management: the company leverages 35+ years of in-house billing expertise to optimize claims documentation and reimbursement, with customers reporting potential annual RPM reimbursements up to $250,000. The platform serves 150,000+ patients and demonstrates clinical outcomes (e.g., 76.3% average blood pressure reduction). Implementation occurs within two weeks, supported by certified trainers, dedicated implementation coordinators, and ongoing technical support. CoachCare targets outpatient care delivery across primary care, cardiology, and chronic disease management use cases.

Scope Healthcare Services is a New York State Licensed Home Care Service Agency (LHCSA) providing in-home personal care and support services to individuals across Queens, Nassau, and Suffolk counties. The organization delivers in-home assistance with activities of daily living including cleaning, laundry, nutrition support, medication reminders, vital signs monitoring, and mobility assistance. The company operates as a Medicaid-participating provider, offering coverage under multiple New York State waiver programs: the Consumer Directed Personal Assistance Program (CDPAP), Home and Community-Based Services Traumatic Brain Injury (HCBS/TBI) Waiver, and Home and Community-Based Services Nursing Home Transition and Diversion (HCBS/NHTD) Waiver. For qualified Medicaid beneficiaries, services may be covered at up to 100% of allowable charges. The agency employs specifically trained personal care assistants and focuses on enabling clients to remain healthy and safe within their communities. Service areas include Rego Park, Jamaica, Astoria, Long Beach, East Meadow, Commack, Bay Shore, and other communities throughout the greater New York region.

Hero is a smart medication management platform founded in 2012 that helps individuals and caregivers manage complex medication regimens. The company offers an all-inclusive subscription service combining a Wi-Fi-enabled smart dispenser device, mobile app, and 24/7 support. The Hero Smart Dispenser automatically sorts and dispenses medications at scheduled times with one-button activation, stores up to a 90-day supply of 10 different medications, and features safety controls including passcode protection and low-pill alerts. The connected Hero app tracks medication schedules, provides dynamic reminders, enables caregiver monitoring, and supports up to 10 additional medications outside the device. Hero is HIPAA-compliant, FDA-registered, and operates on a subscription model starting at $29.99/month with a 30-day money-back guarantee and limited lifetime warranty. The platform collaborates with healthcare providers for Remote Therapeutic Monitoring across 43 states.

Calze G.T. S.r.l., operating under the Relaxsan brand since 1984, is an Italian manufacturer of graduated compression hosiery and therapeutic garments. The company specializes in compression socks, stockings, and leggings for circulatory health, venous insufficiency prevention, and post-surgical thromboembolism prophylaxis. Product lines include Relaxsan (preventive compression hosiery), Medicale (orthopedic therapeutic compression garments), Cotton Socks (cotton-blend compression socks), and Diabetic Socks (non-compression socks for sensitive feet). The company also manufactures compression sportswear, thermal underwear (Zero° line using merino wool and Dryarn), posture-support apparel (Posture Reminder T-Shirt), and personal protective equipment including silver-infused masks and gloves under the UNIMA brand. All products are manufactured 100% in Italy and distributed across 65+ countries. The company emphasizes sustainable materials, including the Repetita® recyclable polyester fiber from post-consumer plastic bottles (GRS-certified). Compression garments are available in preventive (Class I) and medical/therapeutic (Class II) grades, with open-toe options for specific foot conditions. Manufacturing capabilities include textile engineering, compression knitting, and finishing for both consumer and clinical applications.

HALO is a consumer sleep solutions company that has served over 40 million families for 30+ years. The company manufactures and sells a comprehensive range of infant and toddler sleep products, including the flagship BassiNest Swivel Sleeper (bedside bassinet with swivel and height-adjustment features), SleepSack wearable blankets and swaddles (available in multiple thermal ratings and age-appropriate designs), and the Baby Merlin Sleep Suit. HALO also distributes nursery furniture through a partnership with Child Craft, offering convertible cribs (4-in-1 models), toddler beds, dressers, nightstands, and changing tables. Products are designed to reduce startle reflex, support safe sleep practices, and facilitate age-appropriate sleep transitions from newborn through toddler stages. The company reports 98% parent satisfaction and claims 1,500+ hospitals use HALO products. All products are marketed for residential use; no medical device claims or regulatory certifications (FDA 510(k), ISO) are evident from the website. The BassiNest line is prominently featured as a near-sleep solution for co-sleeping and ease of overnight care.

Ondamed Inc. manufactures biofeedback medical devices based on 30+ years of European research and clinical use. The company offers non-invasive therapeutic technologies classified as Class II-a medical devices by the FDA, approved for use in clinical and home settings in the United States. ONDAMED devices employ personalized biofeedback methodology to help patients improve stress tolerance and emotional regulation through relaxation training and body awareness. The technology operates on the principle that stress is linked to common disease states, and addresses this through patient-centered, individualized treatment protocols. The devices are regulated as biofeedback medical devices in the US; regulatory classification varies internationally. ONDAMED has established a global presence across North and South America, Europe, Asia, and Australia. Biofeedback sessions using ONDAMED devices may be covered by Medicare, Medicaid, and private insurance carriers; CPT codes are available. The company positions its approach as personalized medicine, enabling patients to take an active role in their health outcomes while clinicians guide treatment. Products are designed for both clinical practice and home-use applications.

Viora Health is a digital health and lifestyle management company that delivers technology-enabled, evidence-based programs for chronic disease prevention and management. The company develops app-supported, educator-led interventions designed to engage patients in lifestyle modification across nutrition, exercise, behavioral health, and social support. Viora's platform targets conditions including prediabetes, type 2 diabetes, obesity, hypertension, and general chronic disease management, with particular emphasis on culturally competent, trauma-informed care and social determinants of health. The company offers both direct-to-patient enrollment through clinical partnerships and B2B solutions for healthcare systems, primary care practices, and community health centers seeking to scale lifestyle medicine without increasing clinical headcount. Viora's programs are validated by multiple NIH-funded randomized controlled trials and have received full CDC recognition for diabetes prevention (National Diabetes Prevention Program). The company is backed by the National Institutes of Health, American Heart Association, CDC, Johnson & Johnson Innovation Fund, and other institutional partners. Clinical outcomes reported include up to 3-point HbA1C improvements, weight loss up to 49 lbs, and 75% stress reduction among program participants. Viora collects longitudinal patient-reported data to inform care decisions, improve appointment adherence, and provide real-time patient engagement between clinical visits.

Intersurgical is a global designer, manufacturer, and supplier of high-quality medical devices specializing in respiratory care and airway management. The company provides flexible patient solutions across four primary product lines: Airway Management (airway devices, accessories, patient connections, breathing filters, HMEs, HMEFs, and atomisation devices); Anaesthesia (face masks, breathing and resuscitation systems, carbon dioxide absorbents, and head positioning devices); Critical Care (patient interfaces, breathing systems, CPAP devices, oral care, and closed suction systems for ventilatory support); and Oxygen and Aerosol Therapy (fixed and variable concentration oxygen therapy, aerosol therapy, humidification, and nebulisation products). The company serves emergency care, hospital, and home care settings. Intersurgical maintains comprehensive product documentation systems, educational resources, and clinical evidence materials. The organization operates through a global sales network with multiple regional offices and distributors. The company demonstrates commitment to quality and environmental management standards and publishes annual sustainability reports. Intersurgical offers neonatal and pediatric product lines, sterile ranges, and home care ranges supported by detailed product catalogues and instructional documentation.

2San LLC is a consumer health diagnostics company specializing in at-home self-testing products for rapid health assessment. The company manufactures and distributes point-of-care diagnostic tests enabling consumers to obtain results in approximately 10 minutes with reported accuracy rates averaging 98.9%. Their product portfolio spans health and wellness screening, infectious disease detection (including COVID-19 rapid tests), drugs of abuse screening, and family planning diagnostics. 2San has sold over 1.5 million COVID-19 rapid pen tests and maintains distribution through 25+ pharmacy chains across North America. The company operates multiple consumer health brands including Own (self-testing platform), No Ordinary (gloves and protective products), and SwimCount (fertility diagnostics). Their business model focuses on making diagnostic testing accessible to consumers for self-directed health management and informed decision-making regarding medical treatment pathways. The company leverages retail pharmacy channels for product availability and consumer engagement, supporting the shift toward preventive self-testing and personal health monitoring.

Wesper Inc. is an FDA-cleared provider of at-home sleep apnea testing (HSAT) using wearable patch technology. The company delivers Level 3 clinical-grade diagnostic data for sleep disorders without the constraints of traditional polysomnography or conventional home sleep tests. Wesper's proprietary flexible patch-based system captures comprehensive signals including thoracic and abdominal respiratory effort, airflow, oxygen saturation (SpO2), heart rate, sleep staging, body position, snoring, skin temperature, and leg movement analysis. The platform generates 45 longitudinal trend metrics, including AHI 3%/4%, hypoxic burden, ODI, RDI, central apnea index, and T90, delivered through cloud-based provider portals with autoscored and overscored reporting capabilities. The device employs durable silicone construction with gentle adhesives designed for all-night wear across diverse patient populations. Wesper reports a 99% patient success rate and has conducted validation studies comparing its technology to polysomnography across varied demographics (age, ethnicity, BMI, comorbidities). The company markets to sleep medicine practices, primary care providers, and health systems. Regulatory approval includes FDA 510(k) clearance. Clinical evidence and validation documents are published and available for provider review.

Natural Cycles Nordic AB is a Swedish digital health company that develops and distributes an FDA-cleared, algorithm-based contraceptive app and wearable device system for menstrual cycle tracking, fertility planning, pregnancy monitoring, and perimenopause management. The platform serves over 6 million users globally and is certified in 35+ countries. NC° Birth Control delivers 93% typical-use effectiveness and 98% perfect-use effectiveness—equivalent to oral contraceptives—without hormonal side effects. The system combines basal body temperature monitoring via wearable integration with proprietary machine-learning algorithms that personalize fertility predictions to individual cycle patterns rather than assuming standard 28-day cycles. The company markets multiple integrated modules: NC° Birth Control (contraception), NC° Plan Pregnancy (fertility optimization), NC° Follow Pregnancy (pregnancy tracking), NC° Postpartum (recovery support), and NC° Perimenopause (hormone change management). Natural Cycles holds FDA 510(k) clearance for 8+ years and is backed by 27 peer-reviewed studies. The company emphasizes data privacy compliance, including advanced cybersecurity protections mandated for regulated medical devices. Revenue model is subscription-based (monthly or annual plans) plus device costs, avoiding third-party data monetization. Distributed globally through direct-to-consumer digital channels and supported by clinical advisors including OB-GYN specialists.

Unplugs Hearing Inc manufactures audiologist-designed hearing protection devices that enable users to toggle between noise reduction and ambient sound awareness without removing the earpieces. The flagship product, Unplugs, features a mechanical click mechanism (no electronics, batteries, or apps) that allows seamless switching between two acoustic modes: full noise isolation and open listening. Designed by a team led by Dr. Natan Bauman (Columbia University PhD, 40+ years in audiology, inventor of receiver-in-canal technology) and Ralph Campagna (co-inventor of RIC hearing aid technology, 30+ years clinical experience), the devices employ 10+ years of R&D and leverage 70+ years of combined audiology expertise. The product targets active consumers and noise-sensitive individuals in use cases including music festivals, workplace focus environments, travel/commute settings, and sensory-sensitive situations. Unplugs prioritize comfort for extended wear and premium sound clarity in both modes. The company offers pre-order sales through direct-to-consumer channels with accessories including magnetic leash security and engineered fit wings for active use.

Proactive Medical Products LLC is a manufacturer of durable medical equipment (DME) with over 30 years of experience serving long-term care, homecare, hospice, and acute care markets. The company specializes in pressure redistribution and patient safety solutions including low air loss and alternating pressure mattresses, beds, wheelchairs, wheelchair cushions, patient lifts, walkers, and fall management products. Their product portfolio encompasses air and foam mattresses designed for pressure ulcer prevention, mobility aids, safe patient handling equipment, and respiratory/diagnostic devices. The company operates a comprehensive private label program enabling healthcare distributors and DME dealers to customize products with their branding. Proactive Medical maintains an in-stock guarantee program and actively serves B2B channels including DME distributors, medical product retailers, and healthcare facilities. The company emphasizes product quality and customer service availability across their distribution network. Manufacturing capabilities extend to both standard and custom configurations for healthcare provider requirements.

Eforto Health develops the Eforto® System, a validated medical device and software platform for monitoring muscle strength, muscle fatigability, and self-perceived fatigue as biomarkers of vitality capacity (WHO definition). The company offers a comprehensive solution comprising the Eforto® Vigorimeter (an ergonomic handheld grip strength device with medical-grade pressure sensor and auto-calibration), a guided mobile app with validated protocols, and Eforto® Metrics for remote patient monitoring and insightful reporting. The system completes testing in under 5 minutes and supports self-testing at home with interactive app guidance. Core applications include clinical healthcare (disease management, rehabilitation decision-support), health and fitness (muscle health tracking), and clinical research with customizable protocols. The platform is trusted by major medical institutions including Kansas University Medical Center, Erasmus Medical Center, Radboud UMC, and VU Brussels. All data processing is HIPAA, GDPR, and ISO 27001 compliant with FHIR API interoperability. Clinical validation is published in The Lancet Healthy Longevity and Springer journals.

PharmAdva develops the MedaCube, a clinically validated automatic medication dispenser designed to improve medication adherence for seniors, caregivers, and healthcare providers. The device holds up to a 90-day supply of 16 medications and features audio/visual dispensing alerts, caregiver notifications for missed or late doses, refill alerts, tamper-proof security with metal lock, touchscreen interface, WiFi/cellular connectivity, real-time photo documentation of each dose, and backup battery. The MedaCube has demonstrated industry-leading results in published clinical trials and addresses the estimated $300B annual medication adherence challenge in the U.S. Designed for patients with dementia and aging individuals seeking to maintain independent living, the device integrates cloud-based medication management with no monthly subscription fees. Over 100 million pills have been dispensed using the MedaCube platform since commercial launch in 2016.

Aptar Digital Health, a division of Aptar Pharma and part of AptarGroup, Inc., is a comprehensive digital health solutions provider headquartered in Congers, New York. The company specializes in developing and deploying regulated digital therapeutics, companion mobile applications, and connected drug-delivery systems tailored for pharmaceutical and biotechnology partners globally. Aptar Digital Health operates across 120 countries with 20+ years of digital health leadership, supporting 15+ regulatory approvals and 17+ clinical studies. The platform is ISO 13485 and ISO 27001 certified, MDSAP-compliant, and adheres to HIPAA and GDPR standards. Core offerings include Software as a Medical Device (SaMD), Digital Patient Support Programs (PSPs), Disease Management Platforms, and Real-World Evidence generation services. Therapeutic focus areas encompass oncology, respiratory care, neurology (migraine, multiple sclerosis), immunology, and chronic disease management. The company's integrated platform enables pharmaceutical partners to enhance treatment adherence, optimize patient engagement across the entire treatment journey, and generate actionable clinical insights through connected devices and user community analytics.

CathCare manufactures PortPouch™, an innovative IV catheter protection device designed to reduce infection risk, prevent catheter dislodgement, and improve patient comfort during long-term intravenous therapy. The product features a soft, breathable cover with a transparent window for easy site assessment, secure silicone grip strips, and sterile design. PortPouch™ addresses critical challenges in IV management across pediatric, geriatric, oncology, and general hospital populations, as well as home care and outpatient settings. Clinical evidence shows the device reduces catheter-related bloodstream infections, lowers hospital readmission rates, decreases nursing time for catheter resecuring, and supports earlier discharge. The product is trusted by hospitals, home healthcare providers, nurses, and patients seeking enhanced catheter site protection and emotional reassurance during treatment.

TytoCare is an AI-powered remote physical examination platform that enables clinicians to conduct comprehensive diagnostic exams from any location—home or community site. The company's Smart Clinic solutions include FDA-cleared hardware (digital stethoscopes, examination cameras) and advanced diagnostic software that replicates in-person clinical assessments for heart, lungs, throat, ears, skin, abdomen, and vital signs (temperature, heart rate). TytoCare serves 240+ healthcare organizations, 1.6M+ patients, and 40K+ providers globally, with deep integrations across health systems, health plans, and Medicaid programs. The platform features FDA-cleared AI algorithms for detection of pulmonary abnormalities (wheeze, rhonchi, crackles) and clinical decision support. Two primary offerings: Home Smart Clinic for patient self-exams with remote clinician supervision, and Pro Smart Clinic for field-based clinician-conducted exams. Clinical evidence demonstrates 6X higher utilization versus traditional telehealth, 98% remote resolution rate, 8.5% total cost-of-care reduction, and 83 NPS score. Trusted by Corewell Health, Sanford Health, Clalit, Elevance, Presbyterian, and major U.S. health systems.

Eforto develops and markets the Eforto® System, a validated digital solution for monitoring muscle health and vitality capacity through grip strength testing and muscle fatigability assessment. The platform comprises three integrated components: the Eforto® Vigorimeter (a medical-grade ergonomic handgrip dynamometer with auto-calibration pressure sensor, weighing only 100g for use across all patient populations), the Eforto® App (providing guided self-testing with validated protocols delivering results in under 5 minutes), and Eforto® Metrics (a cloud-based remote monitoring dashboard with FHIR API integration for tracking biomarkers over time and generating actionable insights via traffic-light color-coded reporting). The system measures grip strength, muscle fatigability, and self-perceived fatigue as biomarkers for vitality capacity per WHO definition. Clinical evidence is published in The Lancet Healthy Longevity and Springer journals, establishing validity and reliability in older persons. The solution serves three market segments: health & fitness (consumer wellness and health span expansion), medical & healthcare (clinical decision-making, rehabilitation, and disease management), and clinical research (customizable research protocols). Trusted by academic medical centers including Kansas University Medical Center, Erasmus MC, and Radboud UMC. Compliant with HIPAA, GDPR, and ISO 27001; supports interoperable data processing and secure cloud infrastructure. Suitable for hospital rehabilitation departments, primary care, geriatric clinics, and home-based monitoring programs.

Fabrication Enterprises Inc. (FEI) is a manufacturer, importer, and master distributor specializing in rehabilitation, therapy, and daily living products. Founded in 1974 and headquartered in Elmsford, New York, FEI serves hospitals, clinics, fitness centers, and individual consumers through a global network of dealers. The company offers a comprehensive portfolio under multiple brands including Baseline®, CanDo®, FabLife™, Theraputty®, Relief Pak®, ValuBand®, WaxWel®, Dipsters®, and others. Products span evaluation instruments, exercise and rehabilitation equipment, mobility aids, therapeutic modalities (including heat/cold therapy and ultrasound), occupational therapy tools, athletic training supplies, sports medicine equipment, home healthcare products, aids for daily living, topical analgesics, and personal protective equipment. FEI emphasizes dealer support with flexible ordering (no minimums), no drop-ship fees, competitive pricing, and marketing assistance. Many products are manufactured in the USA and CE-marked for international distribution. The company maintains robust inventory for immediate shipment and serves physical therapy, occupational therapy, chiropractic care, athletic training, and wellness markets.

Seroclinix is a diagnostic testing company offering analyzer-based quantitative urinalysis solutions and at-home laboratory testing services. The company provides fully-automated in-clinic chemistry analyzers with reagent test solutions as upgrades from conventional urinalysis test strips, delivering more reliable and informative results. For at-home blood sample collection, Seroclinix employs state-of-the-art technologies including VAMS® (volumetric absorptive microsampling) and LC-MS (liquid chromatography–mass spectrometry) for sample collection and laboratory analysis. The platform enables both in-clinic and at-home sample collection, with integrated user interfaces, sample shipping, processing, and result reporting systems. Seroclinix serves both human healthcare and veterinary markets, emphasizing patient engagement, compliance, and operational efficiency. The company focuses on removing barriers to frequent, proactive testing through micro-sampling kits designed for home use. Markets include primary care clinics, veterinary practices, and telehealth providers. Products are positioned for specialized diagnostic testing across multiple patient populations.

Aerotel Medical Systems is a global provider of remote patient monitoring and telemedicine solutions specializing in 12-lead ECG cardiac monitoring. The company manufactures portable, user-friendly ECG devices combined with cloud-based call center software and transtelephonic transmission capabilities for real-time patient data transfer via Internet, cellular, or telephone networks. Aerotel's product portfolio includes the HeartView 12L (professional handheld 12-lead ECG), HeartView P12/8i (Bluetooth-enabled personal ECG recorder), and HeartView P12/8 Mobile (home monitoring device with cellular modem and voice assistance). The company serves ambulance services, hospitals, telemedicine providers, and home monitoring programs globally. Aerotel's HeartView P12/8 has demonstrated clinical efficacy in published peer-reviewed research showing reduced in-hospital mortality when deployed by ambulance services. The company has successfully completed large-scale national projects, including equipping Hungary's national ambulance service (OMSZ) with ECG monitoring capabilities. Products incorporate voice-guided protocols to enable non-medical personnel to obtain hospital-grade ECG recordings. The company emphasizes one-stop integration support from solution design through implementation and ongoing operations. Founded in 1998, Aerotel maintains global headquarters in Holon, Israel, with international distribution through medical device distributors and service partners.

Healthy.io Ltd. develops smartphone-based clinical diagnostic solutions using computer vision, colorimetric analysis, and AI algorithms to enable remote patient testing from home. The company's core offering transforms a patient's smartphone camera into a clinical-grade medical device capable of analyzing urine tests for early detection of kidney disease and chronic wound assessment. The platform is FDA-cleared and CE-marked, featuring seamless EMR integration via SMART on FHIR standards. Products include Minuteful Kidney for home-based kidney function testing and Minuteful Wound for wound care assessment. The company partners with health systems, health plans (including Medica and Blue Cross of Idaho), and wound care providers to improve screening completion rates, advance health equity, and close the care loop with post-test services. The technology operates across varying devices and lighting conditions, achieving 93% patient satisfaction and up to 50% completion rates among previously untested populations. Healthy.io targets at-risk patient populations, rural communities, and healthcare systems seeking to address the gap where 90% of individuals with chronic kidney disease remain undiagnosed.

Nissha Medical Technologies is a global design and contract manufacturing partner specializing in single-use medical technologies and clinical consumables. Operating under parent company Nissha (established 1929, publicly traded), the organization manufactures and distributes patient monitoring equipment, medical surgical consumables, and complex minimally invasive surgical devices. Core capabilities include clinical wearables with electronics and sensor integration, minimally invasive surgical device design and fabrication, clinical accessories, cable assemblies, and specialty packaging. The company serves hospitals and clinical centers across North America, Europe, and Japan, with direct sales and customer service teams; additionally distributes through an authorized distributor network reaching over 60 countries. Manufacturing and innovation centers span multiple locations: Buffalo, NY (global corporate headquarters), Torbay, UK (European headquarters), Cergy, France, Innsbruck, Austria (regulatory center), Colorado Springs, CO, Sandpoint, ID (innovation center), Nashville, TN (engineering center of excellence), Norwalk, OH, New Richmond, WI, and Dominican Republic. The company offers private-label product options and leverages decades of experience in precision manufacturing. Founded as Graphic Controls in 1909, the organization maintains expertise in printed and converted medical products for industrial and clinical monitoring applications.

BioSignal is a neurodiagnostic company specializing in functional brain assessment via portable EEG technology. The company's FDA-approved microEEG® solution is a miniature, wireless clinical platform enabling rapid electroencephalogram (EEG) recording with cloud-based remote interpretation. BioSignal serves traditional neurology settings (epilepsy centers, sleep labs, neurology departments, ICUs) and expands brain function assessment into novel environments including emergency departments, NICUs, physician offices, ambulances, and home care. The platform supports sports concussion management, traumatic brain injury assessment, routine EEG monitoring, and STAT EEG capabilities. Applications span clinical neurology, emergency medicine, pediatric critical care, sleep medicine, sports medicine, and home sleep monitoring. The solution combines hardware portability with interpretive software to enable rapid assessment and telemedicine-capable EEG interpretation.

Sword Health is a digital health platform providing AI-powered clinical care delivery across musculoskeletal (MSK), women's health, mental health, and cardiometabolic conditions. The company operates a hybrid clinical model combining licensed physical therapists and clinical specialists with proprietary AI Care technology to deliver personalized treatment at scale. Primary offerings include: Thrive (digital physical therapy for pain and MSK conditions with proven surgery reduction and cost savings); Bloom (clinician-led women's health program covering fertility, pelvic health, and menopause); Pulse (cardiometabolic care for blood pressure, weight, glucose, and cholesterol management); Mind (psychologist-led mental health and EAP services); Predict (AI engine for surgical risk identification); and Academy (clinical education content). The platform is FDA-cleared, HIPAA-compliant, HiTrust-certified, Health Canada-approved, and SOC 2 Type II certified. Sword serves health plans, employers, labor unions, and direct-to-consumer members. Reported outcomes include 3:1 average gross ROI, $3,177 annual member savings, 55% surgery avoidance rate among enrolled members, 69% pain-free outcomes, and 9/10 member satisfaction. The company integrates wearable devices and mobile apps for remote patient monitoring and engagement.

Ascent Consumer Products is a consumer healthcare company founded by a pharmacist with roots in the Little Remedies brand. The company develops and markets over-the-counter health and wellness products targeting common health issues across multiple consumer segments, including adults, children, and families. Product lines include nasal care solutions (SinuCleanse brand), wound and piercing care (MediCleanse brand), pediatric remedies (PediaMeds brand), oral care treatments (Zilactin brand), sleep aids (Sleepinal brand), respiratory protection masks (Inhalo brand), and inhalation therapy products (vapor-based delivery systems). All products are manufactured using high-quality ingredients in certified facilities. The company emphasizes research-backed formulations, consumer safety, and efficacy. Ascent operates with a commitment to integrity, quality assurance, and responsible supply chain management. The company serves the retail consumer healthcare market through direct-to-consumer and retail channels. While not positioned as a medical device manufacturer for institutional clinical use, the product portfolio includes consumer-grade wellness and first-aid solutions designed for home use and self-care management.

Complete Medical Supplies Inc. is a nationwide wholesale distributor and manufacturer of healthcare products, founded in 1988. Operating from a 80,000 square-foot facility in Suffern, New York, the company maintains inventory of over 12,000 medical and healthcare products sourced from approximately 500 vendors. Complete Medical specializes in both widely-stocked popular products and difficult-to-source specialty items across multiple clinical categories. The company serves authorized resellers exclusively through B2B channels, offering 24/7 online ordering via their proprietary Complete-Connect platform, comprehensive product catalogs, specification sheets, and vendor management tools. Complete Medical manufactures its own Blue Jay brand line and provides custom student kits for healthcare education institutions. The company emphasizes trained customer service support, drop-shipping capabilities, special pricing for qualified buyers, and comprehensive bid request processing.

Veris Health is a digital health platform specializing in personalized cancer care through remote patient monitoring and clinical connectivity. As a majority-owned subsidiary of PAVmed Inc., the company delivers the Veris Cancer Care Platform—a cloud-based solution enabling continuous bidirectional communication between patients and oncology care teams. The platform integrates physiological data collection via VerisBox™ connected devices, symptom tracking, secure messaging, and scheduled video consultations with EHR interoperability. Features include real-time trend analysis, quality-of-life assessments using EQ-5D™, automated reimbursement documentation, and family/caregiver engagement tools. Available on iOS and Android with Spanish-language support. The platform is HIPAA and SOC compliant and aligns with value-based care models including CMS's Enhancing Oncology Model (EOM). Designed for oncology practices, hospital systems, and cancer centers seeking to improve patient engagement and clinical outcomes through remote monitoring.